Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.

Antiviral research - 1 May 2014

Hsi Edward, Huang Chung-Feng, Dai Chia-Yen, Juo Suh-Hang Hank, Chou Wen-Wen, Huang Jee-Fu, Yeh Ming-Lun, Lin Zu-Yau, Chen Shinn-Cherng, Wang Liang-Yen, Chuang Wan-Long, Yu Ming-Lung

Abstract excerpt

BACKGROUNDS: Chronic hepatitis C virus (HCV) infection has been associated with induction of microRNAs (miRNAs) in peripheral blood mononuclear cells (PBMC). We aimed to evaluate the role of PBMC-miRNAs in the treatment outcome to antiviral therapy for HCV genotype 1 (HCV-1) patients. METHODS: Treatment-naive chronic HCV-1 patients, including 13 in screening phase and 48 in validation phase, were treated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Leukocytes, Mononuclear

Share to MicroRNAs

Share to Real-Time Polymerase Chain Reaction

Share to Ribavirin

Source

Identifiers

PMID: 24637254
DOI: 10.1016/j.antiviral.2014.03.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.PMID 24637254Read ↗

Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.Semantic proximity Read ↗

A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus InfectionSemantic proximity Read ↗

Peripheral blood gene expression profile associated with sustained virologic response after peginterferon plus ribavirin therapy for chronic hepatitis-C genotype 1.Semantic proximity Read ↗

Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients.Semantic proximity Read ↗

The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary StudySemantic proximity Read ↗

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapySemantic proximity Read ↗

IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.Semantic proximity Read ↗

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection.Semantic proximity Read ↗

Hepatic Toll-Like Receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin.Semantic proximity Read ↗

Gene Expression Profiling To Predict and Assess the Consequences of Therapy-Induced Virus Eradication in Chronic Hepatitis C Virus InfectionSemantic proximity Read ↗

Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus TreatmentSemantic proximity Read ↗

Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.